Key points are not available for this paper at this time.
To evaluate the safety, pharmacokinetics, and exploratory efficacy of tivozanib eye drops in healthy volunteers and patients with neovascular age-related macular degeneration (nAMD).
Gomi et al. (Wed,) studied this question.